NCT02105155View on ClinicalTrials.gov

Conversion Prograf® to Advagraf® at D7 Versus D90 After Liver Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

October 17, 2016

Conditions
Immunosuppression After Liver Transplantation
Interventions
DRUG

Conversion at day 7 ± 3 Prograf® to Advagraf®

Conversion from Prograf® (tacrolimus administered twice daily) to Advagraf® (once-daily prolonged-release tacrolimus) at day 7±3

DRUG

Conversion at day 90±5 Prograf® to Advagraf®

Conversion from Prograf® (tacrolimus administered twice daily) to Advagraf® (once-daily prolonged-release tacrolimus) at day 90±5

Trial Locations (1)

75013

Hôpital Pitié Salpêtrière unité médicale de transplantion hépatique, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02105155 - Conversion Prograf® to Advagraf® at D7 Versus D90 After Liver Transplantation | Biotech Hunter | Biotech Hunter